Image

Effect of the "Sitting Out of Bed in an Arm-chair Position" in ICU on Functional Recovery Among Ventilated Patients

Effect of the "Sitting Out of Bed in an Arm-chair Position" in ICU on Functional Recovery Among Ventilated Patients

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Chair positioning is one of a series of early mobilization techniques. At present, this technique, which involves moving a patient out of the resuscitation bed, can be performed passively or actively. It does not constitute a rehabilitative act as such, but it is considered in common paradigms as a technique to improve "the patient's breathing and strength".

However, recommendations issued in 2013 by the Society of intensive care physiotherapy and the society "Société de réanimation de langue française (SRLF)", reveal that this chair position cannot be recommended with a high grade.

The aim of the investigators is therefore to break down this early mobilization process in intensive care, to find out whether the armchair is an indispensable tool for improving functional and muscular processes.

The research hypothesis is therefore as follows:

"Early armchairing of the resuscitation patient, improves functional recovery compared to a conservative positioning strategy (sitting in bed)."

Eligibility

Inclusion Criteria:

  1. Patient > 18 years old
  2. Patient on invasive mechanical ventilation for more than 24 hours
  3. Patient in recovery phase with a RASS score greater than "-3" for more than 12 hours
  4. Stay expected to last 72 hours
  5. Patient has never been placed in a chair during this hospitalization in intensive care.
  6. Fragility score < 6, during the month preceding admission to intensive care
  7. Patient (or support person/relative if patient is unable to participate) who has agreed to take part in the study.

Exclusion Criteria:

  1. Patient with an absolute and non-resolving contraindication to chair positioning
    1. Fracture or orthopedic disorder contraindicating mobilization out of bed
    2. Obesity with body mass index greater than 45 kg/cm2
    3. Sacral eschar stage greater than 2
  2. Patient using a wheelchair for mobility (i.e. paraplegic patient or patient with

    progressive neurological pathology).

  3. Patient treated with veno-venous or veno-arterial ECMO at the time of screening.
  4. Moribund patient
  5. Encephalic death
  6. Acute polyradiculoneuritis (Guillain-Barré syndrome)
  7. Myasthenia
  8. Patient treated by continuous hemodialysis or hemofiltration for more than 72 hours following the onset of awakening.
  9. Complete transmetatarsal or higher amputation of one or both lower limbs.
  10. Protected person (under guardianship or curatorship)
  11. Person under court protection
  12. Person not affiliated to a social security scheme
  13. Pregnant or breast-feeding woman
  14. Patient already included in the study
  15. Patient taking part in an interventional clinical study, the aim of which is to show an improvement in functional level on discharge from the intensive care unit or which focuses on the theme of early rehabilitation in the intensive care unit.

Study details
    ICU Acquired Weakness

NCT06973746

Centre Hospitalier Régional d'Orléans

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.